ID   PLCH2_HUMAN             Reviewed;        1416 AA.
AC   O75038; A2VCM3; B9DI80; Q3LUA8; Q86XJ2; Q86XU1; Q86YU7; Q8TEH5;
AC   Q8WUS6;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 3.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2;
DE            EC=3.1.4.11;
DE   AltName: Full=Phosphoinositide phospholipase C-eta-2;
DE   AltName: Full=Phosphoinositide phospholipase C-like 4;
DE            Short=PLC-L4;
DE            Short=Phospholipase C-like protein 4;
DE   AltName: Full=Phospholipase C-eta-2;
DE            Short=PLC-eta2;
GN   Name=PLCH2; Synonyms=KIAA0450, PLCL4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=16107206; DOI=10.1042/BJ20050839;
RA   Zhou Y., Wing M.R., Sondek J., Harden T.K.;
RT   "Molecular cloning and characterization of PLC-eta2.";
RL   Biochem. J. 391:667-676(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 556-1403 (ISOFORM 4).
RC   TISSUE=Spleen;
RA   Jikuya H., Takano J., Nomura N., Kikuno R., Nagase T., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human
RT   spleen.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RT   "Characterization of cDNA clones in size-fractionated cDNA libraries
RT   from human brain.";
RL   DNA Res. 4:345-349(1997).
RN   [4]
RP   SEQUENCE REVISION.
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 116-1416 (ISOFORM 1), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 143-1416 (ISOFORM 3).
RC   TISSUE=Brain, Pancreas, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: The production of the second messenger molecules
CC       diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is
CC       mediated by activated phosphatidylinositol-specific phospholipase
CC       C enzymes. This phospholipase activity is very sensitive to
CC       calcium. May be important for formation and maintenance of the
CC       neuronal network in the postnatal brain (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 4,5-
CC       bisphosphate + H(2)O = 1D-myo-inositol 1,4,5-trisphosphate +
CC       diacylglycerol.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane. Note=Localized
CC       predominantly at the plasma membrane. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O75038-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75038-2; Sequence=VSP_029068, VSP_029072, VSP_029073;
CC       Name=3;
CC         IsoId=O75038-3; Sequence=VSP_029070;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=O75038-4; Sequence=VSP_029071, VSP_029074;
CC         Note=No experimental confirmation available. Ref.2 (BAB84975)
CC         sequence is in conflict in position: 1004:P->L. {ECO:0000305};
CC       Name=5;
CC         IsoId=O75038-5; Sequence=VSP_029067, VSP_029069, VSP_029071,
CC                                  VSP_029074;
CC         Note=No experimental confirmation available. Ref.2 (BAC56932)
CC         sequence is in conflict in position: 209:Q->L. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Expressed in retina and kidney.
CC       {ECO:0000269|PubMed:16107206}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH43358.1; Type=Frameshift; Positions=172; Evidence={ECO:0000305};
CC       Sequence=BAA32295.3; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAC56932.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ176850; ABA12209.1; -; mRNA.
DR   EMBL; AK074149; BAB84975.1; -; mRNA.
DR   EMBL; AK122591; BAC56932.2; ALT_INIT; mRNA.
DR   EMBL; AB007919; BAA32295.3; ALT_INIT; mRNA.
DR   EMBL; AL139246; CAX30815.1; -; Genomic_DNA.
DR   EMBL; BC019679; AAH19679.1; -; mRNA.
DR   EMBL; BC043358; AAH43358.1; ALT_FRAME; mRNA.
DR   EMBL; BC050037; AAH50037.1; -; mRNA.
DR   EMBL; BC128207; AAI28208.1; -; mRNA.
DR   CCDS; CCDS59959.1; -. [O75038-1]
DR   RefSeq; NP_001289941.1; NM_001303012.1. [O75038-2]
DR   RefSeq; NP_001289942.1; NM_001303013.1.
DR   RefSeq; NP_055453.2; NM_014638.3. [O75038-1]
DR   UniGene; Hs.170156; -.
DR   ProteinModelPortal; O75038; -.
DR   STRING; 9606.ENSP00000367747; -.
DR   iPTMnet; O75038; -.
DR   PhosphoSitePlus; O75038; -.
DR   BioMuta; PLCH2; -.
DR   PaxDb; O75038; -.
DR   PeptideAtlas; O75038; -.
DR   PRIDE; O75038; -.
DR   TopDownProteomics; O75038-1; -. [O75038-1]
DR   Ensembl; ENST00000378486; ENSP00000367747; ENSG00000149527. [O75038-1]
DR   Ensembl; ENST00000419816; ENSP00000389803; ENSG00000149527. [O75038-1]
DR   Ensembl; ENST00000449969; ENSP00000397289; ENSG00000149527. [O75038-2]
DR   Ensembl; ENST00000620687; ENSP00000481938; ENSG00000276429. [O75038-1]
DR   Ensembl; ENST00000626246; ENSP00000486186; ENSG00000276429. [O75038-1]
DR   Ensembl; ENST00000627854; ENSP00000487140; ENSG00000276429. [O75038-2]
DR   GeneID; 9651; -.
DR   KEGG; hsa:9651; -.
DR   UCSC; uc001ajj.2; human. [O75038-1]
DR   CTD; 9651; -.
DR   DisGeNET; 9651; -.
DR   GeneCards; PLCH2; -.
DR   H-InvDB; HIX0000057; -.
DR   HGNC; HGNC:29037; PLCH2.
DR   MIM; 612836; gene.
DR   neXtProt; NX_O75038; -.
DR   OpenTargets; ENSG00000149527; -.
DR   PharmGKB; PA134914471; -.
DR   eggNOG; KOG0169; Eukaryota.
DR   eggNOG; ENOG410XPSW; LUCA.
DR   GeneTree; ENSGT00760000118936; -.
DR   HOVERGEN; HBG107105; -.
DR   InParanoid; O75038; -.
DR   KO; K19006; -.
DR   OMA; CSLETIT; -.
DR   OrthoDB; EOG091G02KH; -.
DR   PhylomeDB; O75038; -.
DR   TreeFam; TF313216; -.
DR   Reactome; R-HSA-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   ChiTaRS; PLCH2; human.
DR   GenomeRNAi; 9651; -.
DR   PRO; PR:O75038; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000149527; -.
DR   CleanEx; HS_PLCH2; -.
DR   ExpressionAtlas; O75038; baseline and differential.
DR   Genevisible; O75038; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; TAS:Reactome.
DR   GO; GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0046488; P:phosphatidylinositol metabolic process; IEA:Ensembl.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR028393; PLC-eta2.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR015359; PLC_EF-hand-like.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336; PTHR10336; 1.
DR   PANTHER; PTHR10336:SF125; PTHR10336:SF125; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF09279; EF-hand_like; 1.
DR   Pfam; PF16457; PH_12; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00054; EFh; 2.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF51695; SSF51695; 2.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Calcium; Cell membrane; Complete proteome;
KW   Cytoplasm; Hydrolase; Lipid degradation; Lipid metabolism; Membrane;
KW   Metal-binding; Phosphoprotein; Reference proteome; Repeat; Transducer.
FT   CHAIN         1   1416       1-phosphatidylinositol 4,5-bisphosphate
FT                                phosphodiesterase eta-2.
FT                                /FTId=PRO_0000088507.
FT   DOMAIN       47    155       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      169    204       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      205    241       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      326    471       PI-PLC X-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00270}.
FT   DOMAIN      626    740       PI-PLC Y-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00271}.
FT   DOMAIN      745    852       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   CA_BIND     182    193       {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   REGION        1    155       Necessary for plasma membrane
FT                                localization. {ECO:0000250}.
FT   ACT_SITE    341    341       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   ACT_SITE    385    385       {ECO:0000255|PROSITE-ProRule:PRU00270}.
FT   METAL       342    342       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       371    371       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       373    373       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       420    420       Calcium 1; catalytic. {ECO:0000250}.
FT   METAL       784    784       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       786    786       Calcium 2. {ECO:0000250}.
FT   METAL       810    810       Calcium 2. {ECO:0000250}.
FT   METAL       839    839       Calcium 3. {ECO:0000250}.
FT   METAL       840    840       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       841    841       Calcium 3. {ECO:0000250}.
FT   BINDING     469    469       Substrate. {ECO:0000250}.
FT   BINDING     471    471       Substrate. {ECO:0000250}.
FT   BINDING     653    653       Substrate. {ECO:0000250}.
FT   BINDING     680    680       Substrate. {ECO:0000250}.
FT   MOD_RES     487    487       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:A2AP18}.
FT   MOD_RES     491    491       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:A2AP18}.
FT   MOD_RES     595    595       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:A2AP18}.
FT   MOD_RES     605    605       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:A2AP18}.
FT   VAR_SEQ       1     45       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_029067.
FT   VAR_SEQ       1     41       MSGPWPSPDSRTKGTVAWLAEVLLWVGGSVVLSSEWQLGPL
FT                                -> MEEPGPPGGLSQDQ (in isoform 2).
FT                                {ECO:0000303|PubMed:9455484}.
FT                                /FTId=VSP_029068.
FT   VAR_SEQ     117    785       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_029069.
FT   VAR_SEQ     706    741       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029070.
FT   VAR_SEQ     987   1211       DTRPLSTQRPLPPLCSLETIAEEPAPGPGPPPPAAVPTSSS
FT                                QGRPPYPTGPGANVASPLEDTEEPRDSRPRPCNGEGAGGAY
FT                                ERAPGSQTDGRSQPRTLGHLPVIRRVKSEGQVPTEPLGGWR
FT                                PLAAPFPAPAVYSDATGSDPLWQRLEPCGHRDSVSSSSSMS
FT                                SSDTVIDLSLPSLGLGRSRENLAGAHMGRLPPRPHSASAAR
FT                                PDLPPVTKSKSNPNLRATGQ -> GKAPAAVAEKSPVRVRP
FT                                PRVLDGPGPAGMAATCMKCVVGSCAGVNTGGLQRERPPSPG
FT                                PASRQAAIRQQPRARADSLGAPCCGLDPHAIPGRSREAPKG
FT                                PGAWRQGPGGSGSMSSDSSSPDSPGIPERSPRWPEGACRQP
FT                                GALQGEMSALFAQKLEEIRSKSPMFSAGKPLLPCVVLPHAP
FT                                GMAGPGSPAAASAWTVSPRVLVLVALYPWHCLRGTLLPWLA
FT                                CGP (in isoform 4 and isoform 5).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_029071.
FT   VAR_SEQ     987   1156       DTRPLSTQRPLPPLCSLETIAEEPAPGPGPPPPAAVPTSSS
FT                                QGRPPYPTGPGANVASPLEDTEEPRDSRPRPCNGEGAGGAY
FT                                ERAPGSQTDGRSQPRTLGHLPVIRRVKSEGQVPTEPLGGWR
FT                                PLAAPFPAPAVYSDATGSDPLWQRLEPCGHRDSVSSSSSMS
FT                                SSDTVI -> GKAPAAVAEKSPVRVRPPRVLDGPGPAGMAA
FT                                TCMKCVVGSCAGVNTGGLQRERPPSPGPASRQAAIRQQPRA
FT                                RADSLGAPCCGLDPHAIPGRSREAPKGPGAWRQGPGGSGSM
FT                                SSDSSSPDSPGIPERSPRWPEGACRQPGALQGEMSALFAQK
FT                                LEEIRSKSPMFSAVRN (in isoform 2).
FT                                {ECO:0000303|PubMed:9455484}.
FT                                /FTId=VSP_029072.
FT   VAR_SEQ    1157   1416       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9455484}.
FT                                /FTId=VSP_029073.
FT   VAR_SEQ    1212   1416       Missing (in isoform 4 and isoform 5).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_029074.
FT   CONFLICT    559    559       D -> E (in Ref. 2; BAB84975).
FT                                {ECO:0000305}.
FT   CONFLICT    560    560       V -> M (in Ref. 2; BAB84975).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1416 AA;  154668 MW;  05088ACD9C45AE87 CRC64;
     MSGPWPSPDS RTKGTVAWLA EVLLWVGGSV VLSSEWQLGP LVERCMGAMQ EGMQMVKLRG
     GSKGLVRFYY LDEHRSCIRW RPSRKNEKAK ISIDSIQEVS EGRQSEVFQR YPDGSFDPNC
     CFSIYHGSHR ESLDLVSTSS EVARTWVTGL RYLMAGISDE DSLARRQRTR DQWLKQTFDE
     ADKNGDGSLS IGEVLQLLHK LNVNLPRQRV KQMFREADTD DHQGTLGFEE FCAFYKMMST
     RRDLYLLMLT YSNHKDHLDA ASLQRFLQVE QKMAGVTLES CQDIIEQFEP CPENKSKGLL
     GIDGFTNYTR SPAGDIFNPE HHHVHQDMTQ PLSHYFITSS HNTYLVGDQL MSQSRVDMYA
     WVLQAGCRCV EVDCWDGPDG EPIVHHGYTL TSKILFKDVI ETINKYAFIK NEYPVILSIE
     NHCSVIQQKK MAQYLTDILG DKLDLSSVSS EDATTLPSPQ MLKGKILVKG KKLPANISED
     AEEGEVSDED SADEIDDDCK LLNGDASTNR KRVENTAKRK LDSLIKESKI RDCEDPNNFS
     VSTLSPSGKL GRKSKAEEDV ESGEDAGASR RNGRLVVGSF SRRKKKGSKL KKAASVEEGD
     EGQDSPGGQS RGATRQKKTM KLSRALSDLV KYTKSVATHD IEMEAASSWQ VSSFSETKAH
     QILQQKPAQY LRFNQQQLSR IYPSSYRVDS SNYNPQPFWN AGCQMVALNY QSEGRMLQLN
     RAKFSANGGC GYVLKPGCMC QGVFNPNSED PLPGQLKKQL VLRIISGQQL PKPRDSMLGD
     RGEIIDPFVE VEIIGLPVDC SREQTRVVDD NGFNPTWEET LVFMVHMPEI ALVRFLVWDH
     DPIGRDFIGQ RTLAFSSMMP GYRHVYLEGM EEASIFVHVA VSDISGKVKQ ALGLKGLFLR
     GPKPGSLDSH AAGRPPARPS VSQRILRRTA SAPTKSQKPG RRGFPELVLG TRDTGSKGVA
     DDVVPPGPGP APEAPAQEGP GSGSPRDTRP LSTQRPLPPL CSLETIAEEP APGPGPPPPA
     AVPTSSSQGR PPYPTGPGAN VASPLEDTEE PRDSRPRPCN GEGAGGAYER APGSQTDGRS
     QPRTLGHLPV IRRVKSEGQV PTEPLGGWRP LAAPFPAPAV YSDATGSDPL WQRLEPCGHR
     DSVSSSSSMS SSDTVIDLSL PSLGLGRSRE NLAGAHMGRL PPRPHSASAA RPDLPPVTKS
     KSNPNLRATG QRPPIPDELQ PRSLAPRMAG LPFRPPWGCL SLVGVQDCPV AAKSKSLGDL
     TADDFAPSFE GGSRRLSHSL GLPGGTRRVS GPGVRRDTLT EQLRWLTVFQ QAGDITSPTS
     LGPAGEGVAG GPGFVRRSSS RSHSRVRAIA SRARQAQERQ QRLQGLGRQG PPEEERGTPE
     GACSVGHEGS VDAPAPSKGA LGPASAAAEN LVLLRL
//
